We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+151.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$601M
AUM Growth
+$166M
Cap. Flow
+$564M
Cap. Flow %
93.74%
Top 10 Hldgs %
55.84%
Holding
582
New
177
Increased
66
Reduced
116
Closed
191

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.9%
2 Healthcare 14.37%
3 Financials 8.14%
4 Industrials 2.53%
5 Technology 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HP icon
351
PUT
Helmerich & Payne
HP
$4.18B
$11K ﹤0.01%
+17,800
New +$347K
GSMGW
352
DELISTED
Cheer Holding, Inc. Warrant expiring 2/13/2025
GSMGW
$11K ﹤0.01%
276,300
-67,500
-20% -$4.56K
AMRN
353
PUT
Amarin Corp
AMRN
$298M
$10K ﹤0.01%
1,125
-8,355
-88% -$1.15M
XBI icon
354
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$10K ﹤0.01%
130,000
+53,000
+69% +$5.22M
MRTX
355
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$10K ﹤0.01%
6,900
+2,200
+47% +$213K
ANDAR
356
DELISTED
Andina Acquisition Corp. III Right
ANDAR
$10K ﹤0.01%
39,855
-397,127
-91% -$72K
APHA
357
CALL
DELISTED
Aphria Inc. Common Shares
APHA
$10K ﹤0.01%
20,000
-5,000
-20% -$19.2K
ZGNX
358
PUT
DELISTED
Zogenix, Inc.
ZGNX
$10K ﹤0.01%
+119,700
New +$3.3M
DLR icon
359
CALL
Digital Realty Trust
DLR
$70.8B
$9K ﹤0.01%
1,400
-8,800
-86% -$1.25M
SLNO
360
CALL
DELISTED
Soleno Therapeutics
SLNO
$9K ﹤0.01%
+11,820
New +$512K
WOR icon
361
PUT
Worthington Enterprises
WOR
$2.79B
$9K ﹤0.01%
+18,815
New +$336K
XLV icon
362
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$44B
$9K ﹤0.01%
+20,000
New +$1.97M
TCO
363
PUT
DELISTED
Taubman Centers Inc.
TCO
$9K ﹤0.01%
8,600
-134,900
-94% -$5.51M
FAST icon
364
PUT
Fastenal
FAST
$59.8B
$8K ﹤0.01%
20,000
PFE icon
365
CALL
Pfizer
PFE
$154B
$8K ﹤0.01%
43,952
-8,748
-17% -$297K
CVNA icon
366
PUT
Carvana
CVNA
$81.5B
$7K ﹤0.01%
+75,000
New +$1.4M
HUN icon
367
PUT
Huntsman Corp
HUN
$1.82B
$6K ﹤0.01%
60,000
HYG icon
368
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$6K ﹤0.01%
14,400
-388,200
-96% -$31.3M
THCAW
369
DELISTED
Tuscan Holdings Corp. II Warrant
THCAW
$6K ﹤0.01%
10,400
-59,143
-85% -$21.4K
QDEL icon
370
PUT
QuidelOrtho
QDEL
$943M
$5K ﹤0.01%
28,200
+15,900
+129% +$2.49M
X
371
CALL
DELISTED
US Steel
X
$5K ﹤0.01%
+112,300
New +$876K
FLXN
372
CALL
DELISTED
Flexion Therapeutics, Inc.
FLXN
$5K ﹤0.01%
15,000
-29,200
-66% -$303K
GNW icon
373
CALL
Genworth Financial
GNW
$3.7B
$4K ﹤0.01%
130,600
+30,300
+30% +$95.4K
PFE icon
374
PUT
Pfizer
PFE
$154B
$4K ﹤0.01%
+52,384
New +$1.78M
USFD icon
375
CALL
US Foods
USFD
$23.9B
$4K ﹤0.01%
+20,700
New +$396K

Similar funds

Cowen and Company's Q2 2020 Portfolio in Review

As of Q2 2020, Cowen and Company held 582 positions worth $601M, up 38% from $435M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Cowen and Company deployed $564M of net new capital in Q2 2020, opening 177 new positions and adding to 66 existing holdings. Its largest new stake was Carnival Corporation Ltd: 1,476,800 shares worth $24.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 4.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $16.1M trimmed.

  • Cowen and Company's largest Q2 2020 buy was Carnival Corporation Ltd: 1,476,800 shares worth $24.2M.
  • Cowen and Company added most to Nikola Corporation Common Stock in Q2 2020, an estimated $23.3M increase.
  • Cowen and Company's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $16.1M.
  • Cowen and Company fully exited Match Group in Q2 2020, selling an estimated $19.8M.
  • Cowen and Company's ten largest holdings make up 56% of its $601M portfolio in Q2 2020.
  • Cowen and Company opened 177 new positions and closed 191 in Q2 2020.
  • Cowen and Company's portfolio value rose 38% quarter-over-quarter to $601M.

Based on Cowen and Company's 13F filing for Q2 2020, filed 13 Aug 2020.